Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Non-Current Assets (2020 - 2023)

Historic Non-Current Assets for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $5.0 million.

  • Candel Therapeutics' Non-Current Assets fell 1645.61% to $5.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $21.4 million, marking a year-over-year decrease of 304.69%. This contributed to the annual value of $5.7 million for FY2022, which is 3488.26% up from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Non-Current Assets is $5.0 million, which was down 1645.61% from $5.3 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Non-Current Assets ranged from a high of $6.3 million in Q2 2021 and a low of $3.1 million during Q4 2020
  • Moreover, its 4-year median value for Non-Current Assets was $5.4 million (2023), whereas its average is $5.3 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 3584.18% in 2021, then plummeted by 1645.61% in 2023.
  • Quarter analysis of 4 years shows Candel Therapeutics' Non-Current Assets stood at $3.1 million in 2020, then soared by 35.84% to $4.3 million in 2021, then surged by 34.88% to $5.7 million in 2022, then dropped by 13.68% to $5.0 million in 2023.
  • Its Non-Current Assets was $5.0 million in Q3 2023, compared to $5.3 million in Q2 2023 and $5.4 million in Q1 2023.